Niclosamide modulates chronic Cryptosporidium-induced ileocecal adenocarcinoma in immunocompromised infected mice via targeting IL-6/IL-22-STAT3 axis

Bibliographic Information
Authors: El-Wakil E.S.; El-Maadawy W.H.; Bayomy A.A.; Shakra M.Y.; Mohamed A.M.A.; Mostafa M.E.S.; Helal H.S.
Journal: Research in Veterinary Science
Publisher: Elsevier B.V.
Publication Date: November 2025
Volume / Issue: Volume 196
Article No.: 105895
ISSN: 345288
DOI: 10.1016/j.rvsc.2025.105895
Scopus: View on Scopus
PubMed: 40967104
Document Type: Article
Authors and Affiliations
El-Wakil E.S., Parasitology Department, Theodor Bilharz Research Institute, Warrak El-Hadar, Imbaba (P.O. 30), Giza, 12411, Egypt; El-Maadawy W.H., Pharmacology Department, Theodor Bilharz Research Institute, Warrak El-Hadar, Imbaba (P.O. 30), Giza, 12411, Egypt; Bayomy A.A., Department of Medical Parasitology, Faculty of Medicine, Al-Azhar University, Cairo, Nasr City, Egypt; Shakra M.Y., Department of Medical Parasitology, Faculty of Medicine, Al-Azhar University, New Dameitta, 34517, Egypt; Mohamed A.M.A., Department of Medical Parasitology, Faculty of Medicine, Al-Azhar University, Cairo, Nasr City, Egypt; Mostafa M.E.S., Department of Medical Parasitology, Faculty of Medicine, Al-Azhar University, New Dameitta, 34517, Egypt; Helal H.S., Department of Medical Parasitology, Faculty of Medicine, Al-Azhar University, New Dameitta, 34517, Egypt
Abstract
Cryptosporidiosis, a protozoal disease caused by Cryptosporidium parvum (C. parvum), is a globally emerging waterborne infection leading to moderate to severe diarrhea, particularly in immunocompromised individuals. Emerging evidence proposes a potential correlation between chronic infection and digestive cancers, though the underlying mechanisms remain unclear. Therapeutic options are minimal, with nitazoxanide (NTZ) being the only drug available, despite its constrained effectiveness. Niclosamide (NICLO), an anthelmintic drug, exhibits antiparasitic properties and modulates oncogenic signaling pathways, making it a promising candidate for dual therapeutic effects. This study investigated NICLO's efficacy against chronic C. parvum infection and its potential to prevent ileocecal adenocarcinoma development in immunocompromised mice. Mice were immunosuppressed using dexamethasone, infected with C. parvum oocysts, and administered NTZ or NICLO. NICLO administration significantly reduced parasite burden by 90 %, restored histopathological alterations, and suppressed C. parvum-induced inflammation, as evidenced by suppressed IL-6 and IL-22 levels and STAT3 activation. NICLO also counteracted the antiapoptotic effects of infection by downregulating Bcl-2 and upregulating Bax and cleaved caspase-3 levels. Moreover, NICLO deactivated the Wnt/β-catenin pathway and its target genes (survivin, c-myc, and cyclin D) while elevating p53 levels. These findings highlight NICLO's dual therapeutic potential, which effectively targets C. parvum infection and mitigates its tumorigenic effects by disrupting key signaling pathways involved in ileocecal cancer progression. This study provides novel insights into NICLO's chemotherapeutic efficacy in managing cryptosporidiosis and its associated oncogenic potential. © 2024
Keywords
Cryptosporidium parvum; Ileocecal adenocarcinoma; Intrinsic apoptosis; Niclosamide; STAT3 signaling; Wnt/β-catenin signaling; Adenocarcinoma; Animals; Cryptosporidiosis; Female; Immunocompromised Host; Interleukin-6; Interleukins; Intestinal Neoplasms; Male; Mice; STAT3 Transcription Factor; baculoviral IAP repeat containing protein 5; beta catenin; caspase 3; cyclin D; dexamethasone; interleukin 22; interleukin 6; Myc protein; nitazoxanide; protein Bax; protein bcl 2; protein p53; STAT3 protein; Wnt protein; interleukin derivative; Stat3 protein, mouse; animal tissue; antiapoptotic activity; antitumorigenic activity; apoptosis; Article; cancer growth; canonical Wnt signaling; carcinogenesis; clinical evaluation; controlled study; down regulation; drug efficacy; evidence based practice; histopathology; ileum tissue; inflammation; mouse; nonhuman; oocyst; parasite load; parasitological parameters; protein targeting; real time polymerase chain reaction; small bowel adenocarcinoma; upregulation; Western blotting; animal; complication; drug therapy; genetics; immunocompromised patient; intestine tumor; metabolism; parasitology; prevention and control
Citation Information
Scopus Citations: 3
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
